ARCHIVES

Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 31, 1975

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

December 14, 2001

DCT Board Okays Recompetition of Drug Discovery Groups

October 22, 1993

NCI Advisory Group, Other Cancer Meetings

February 24, 1989

Institutions Fail To Credit NIH when Patenting discoveries, HHS Says

July 15, 1994